Oncology Based Molecular Diagnostics Market Report

Global and Region Oncology Based Molecular Diagnostics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：144
  • REPORT CODE：GMM944733
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Molecular diagnosis of tumor refers to the molecular biological diagnosis technology with nucleic acid or protein as the core, which is an important method for early diagnosis of tumor.

    The report details the trend, potential and market size of Oncology Based Molecular Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Oncology Based Molecular Diagnosticsmarket, defines the market attractiveness level of Oncology Based Molecular Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Oncology Based Molecular Diagnostics industry, describes the types of Oncology Based Molecular Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oncology Based Molecular Diagnostics market and the development prospects and opportunities of Oncology Based Molecular Diagnostics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oncology Based Molecular Diagnostics market in Chapter 13.

    By Player:

    • Gen Probe(Hologic)

    • Becton Dickinson

    • Bayer Healthcare

    • Siemens Healthcare

    • Roche Diagnostics

    • Abbott Laboratories

    • Cepheid

    • Dako

    • Danaher Corporation

    By Type:

    • PCR

    • Multiplex PCR

    • Isothermal Nucleic Acid Amplification Technology (INAAT)

    By End-User:

    • Breast Cancer

    • Prostate Cancer

    • Colorectal Cancer

    • Cervical Cancer

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Oncology Based Molecular Diagnostics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Oncology Based Molecular Diagnostics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Oncology Based Molecular Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Oncology Based Molecular Diagnostics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Oncology Based Molecular Diagnostics Market Analysis and Outlook to 2022

    • 7.1 Global Oncology Based Molecular Diagnostics Consumption (2017-2022)

    • 7.2 United States Oncology Based Molecular Diagnostics Consumption (2017-2022)

    • 7.3 Europe Oncology Based Molecular Diagnostics Consumption (2017-2022)

    • 7.4 China Oncology Based Molecular Diagnostics Consumption (2017-2022)

    • 7.5 Japan Oncology Based Molecular Diagnostics Consumption (2017-2022)

    • 7.6 India Oncology Based Molecular Diagnostics Consumption (2017-2022)

    • 7.7 South Korea Oncology Based Molecular Diagnostics Consumption (2017-2022)

    8 Region and Country-wise Oncology Based Molecular Diagnostics Market Analysis and Outlook to 2028

    • 8.1 Global Oncology Based Molecular Diagnostics Consumption Forecast (2022-2028)

    • 8.2 United States Oncology Based Molecular Diagnostics Consumption Forecast (2022-2028)

    • 8.3 Europe Oncology Based Molecular Diagnostics Consumption Forecast (2022-2028)

    • 8.4 China Oncology Based Molecular Diagnostics Consumption Forecast (2022-2028)

    • 8.5 Japan Oncology Based Molecular Diagnostics Consumption Forecast (2022-2028)

    • 8.6 India Oncology Based Molecular Diagnostics Consumption Forecast (2022-2028)

    • 8.7 South Korea Oncology Based Molecular Diagnostics Consumption Forecast (2022-2028)

    9 Global Oncology Based Molecular Diagnostics Market Outlook by Types and Applications to 2022

    • 9.1 Global Oncology Based Molecular Diagnostics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global PCR Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Multiplex PCR Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oncology Based Molecular Diagnostics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cervical Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Oncology Based Molecular Diagnostics Market Outlook by Types and Applications to 2028

    • 10.1 Global Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global PCR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Multiplex PCR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Oncology Based Molecular Diagnostics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Oncology Based Molecular Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Oncology Based Molecular Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Oncology Based Molecular Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Oncology Based Molecular Diagnostics Market Competitive Analysis

    • 14.1 Gen Probe(Hologic)

      • 14.1.1 Gen Probe(Hologic) Company Details

      • 14.1.2 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product and Service

    • 14.2 Becton Dickinson

      • 14.2.1 Becton Dickinson Company Details

      • 14.2.2 Becton Dickinson Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Becton Dickinson Oncology Based Molecular Diagnostics Product and Service

    • 14.3 Bayer Healthcare

      • 14.3.1 Bayer Healthcare Company Details

      • 14.3.2 Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer Healthcare Oncology Based Molecular Diagnostics Product and Service

    • 14.4 Siemens Healthcare

      • 14.4.1 Siemens Healthcare Company Details

      • 14.4.2 Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Siemens Healthcare Oncology Based Molecular Diagnostics Product and Service

    • 14.5 Roche Diagnostics

      • 14.5.1 Roche Diagnostics Company Details

      • 14.5.2 Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Roche Diagnostics Oncology Based Molecular Diagnostics Product and Service

    • 14.6 Abbott Laboratories

      • 14.6.1 Abbott Laboratories Company Details

      • 14.6.2 Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Abbott Laboratories Oncology Based Molecular Diagnostics Product and Service

    • 14.7 Cepheid

      • 14.7.1 Cepheid Company Details

      • 14.7.2 Cepheid Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cepheid Oncology Based Molecular Diagnostics Product and Service

    • 14.8 Dako

      • 14.8.1 Dako Company Details

      • 14.8.2 Dako Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Dako Oncology Based Molecular Diagnostics Product and Service

    • 14.9 Danaher Corporation

      • 14.9.1 Danaher Corporation Company Details

      • 14.9.2 Danaher Corporation Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Danaher Corporation Oncology Based Molecular Diagnostics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Oncology Based Molecular Diagnostics

    • Figure Oncology Based Molecular Diagnostics Picture

    • Table Global Oncology Based Molecular Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oncology Based Molecular Diagnostics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oncology Based Molecular Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Oncology Based Molecular Diagnostics Consumption by Country (2017-2022)

    • Figure United States Oncology Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Table Europe Oncology Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure China Oncology Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Japan Oncology Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure India Oncology Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oncology Based Molecular Diagnostics Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Based Molecular Diagnostics Consumption Forecast by Country (2022-2028)

    • Figure United States Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oncology Based Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global PCR Consumption and Growth Rate (2017-2022)

    • Figure Global Multiplex PCR Consumption and Growth Rate (2017-2022)

    • Figure Global Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global PCR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiplex PCR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Isothermal Nucleic Acid Amplification Technology (INAAT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Oncology Based Molecular Diagnostics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Oncology Based Molecular Diagnostics Export by Region (Top 5 Countries) (2017-2028)

    • Table Gen Probe(Hologic) (Foundation Year, Company Profile and etc.)

    • Table Gen Probe(Hologic) Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gen Probe(Hologic) Oncology Based Molecular Diagnostics Product and Service

    • Table Becton Dickinson (Foundation Year, Company Profile and etc.)

    • Table Becton Dickinson Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson Oncology Based Molecular Diagnostics Product and Service

    • Table Bayer Healthcare (Foundation Year, Company Profile and etc.)

    • Table Bayer Healthcare Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Oncology Based Molecular Diagnostics Product and Service

    • Table Siemens Healthcare (Foundation Year, Company Profile and etc.)

    • Table Siemens Healthcare Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthcare Oncology Based Molecular Diagnostics Product and Service

    • Table Roche Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Roche Diagnostics Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Diagnostics Oncology Based Molecular Diagnostics Product and Service

    • Table Abbott Laboratories (Foundation Year, Company Profile and etc.)

    • Table Abbott Laboratories Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Oncology Based Molecular Diagnostics Product and Service

    • Table Cepheid (Foundation Year, Company Profile and etc.)

    • Table Cepheid Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cepheid Oncology Based Molecular Diagnostics Product and Service

    • Table Dako (Foundation Year, Company Profile and etc.)

    • Table Dako Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dako Oncology Based Molecular Diagnostics Product and Service

    • Table Danaher Corporation (Foundation Year, Company Profile and etc.)

    • Table Danaher Corporation Oncology Based Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation Oncology Based Molecular Diagnostics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US